Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sedana Medical AB ( (SE:SEDANA) ) has issued an update.
Sedana Medical AB is set to release its interim report for the second quarter of 2025 on July 18, with a presentation scheduled for the same day. The report will be presented by the CEO, CFO, and CMO, providing insights into the company’s performance and strategy, which could impact its market positioning and stakeholder interests.
More about Sedana Medical AB
Sedana Medical AB is a medtech and pharmaceutical company specializing in inhaled sedation for mechanically ventilated patients in intensive care. The company offers the Sedaconda ACD medical device and Sedaconda (isoflurane) pharmaceutical, with direct sales in several European countries and partnerships in other global regions. Founded in 2005, Sedana Medical is listed on Nasdaq Stockholm and headquartered in Stockholm, Sweden.
Average Trading Volume: 375,874
Current Market Cap: SEK1.18B
Find detailed analytics on SEDANA stock on TipRanks’ Stock Analysis page.